No Data
Beijing Hotgen Biotech Co.,Ltd (688068.SH): Has not started the share repurchase yet.
According to Gelonghui on December 3, Beijing Hotgen Biotech Co., Ltd (688068.SH) announced that as of November 30, 2024, the company has not yet begun the repurchase.
Beijing Hotgen Biotech Co.,Ltd (688068.SH) identified Chen Jiangguo as a core technical staff member.
Beijing Hotgen Biotech Co., Ltd (688068.SH) announced that Chen Jianguo has been newly recognized as a core technical personnel of the company, replacing the original core technical...
Beijing Hotgen Biotech Co., Ltd (688068.SH) and its subsidiaries recently obtained 18 qualifications.
Beijing Hotgen Biotech Co., Ltd (688068.SH) issued an announcement that the company and its subsidiaries have recently obtained domestic medical instruments registration certificates.
Hejing Biotech: Beijing Hejing Biotechnology Co., Ltd. Report for the Third Quarter of 2024
Beijing Hejing Biotechnology Co., Ltd. Report for the Third Quarter of 2024
beijing hotgen biotech co.,ltd (688068.SH) released its performance for the first three quarters, with a net loss of 40.6386 million yuan.
Beijing Hotgen Biotech Co.,Ltd. (688068.SH) released the third quarter report for 2024, with revenue for the first three quarters of the company reaching ...
